Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Obstetrics/Gynecology (Women’s Health) | Family Medicine | Gastroenterology
Cervical Cancer Clinical Trials
A listing of Cervical Cancer medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.
Filter by:
Phase:
All
N/A
0
1
1/2
2
2/3
3
4
Gender:
Both
Male
Female
Age:
Location:
All
US: Alabama
US: Alaska
US: Arizona
US: Arkansas
US: California
US: Colorado
US: Connecticut
US: Delaware
US: District of Columbia
US: Florida
US: Georgia
US: Hawaii
US: Idaho
US: Illinois
US: Indiana
US: Iowa
US: Kansas
US: Kentucky
US: Louisiana
US: Maine
US: Maryland
US: Massachusetts
US: Michigan
US: Minnesota
US: Mississippi
US: Missouri
US: Montana
US: Nebraska
US: Nevada
US: New Hampshire
US: New Jersey
US: New Mexico
US: New York
US: North Carolina
US: North Dakota
US: Ohio
US: Oklahoma
US: Oregon
US: Pennsylvania
US: Rhode Island
US: South Carolina
US: South Dakota
US: Tennessee
US: Texas
US: Utah
US: Vermont
US: Virgin Islands
US: Virginia
US: Washington
US: West Virginia
US: Wisconsin
US: Wyoming
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island And Mcdonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle Of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts And Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and The Grenadines
Samoa
San Marino
Sao Tome And Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard And Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad And Tobago
Tunisia
Turkey
Turkmenistan
Turks And Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis And Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
First 1 2 3 Last
Alabama
University of Alabama at Birmingham
Birmingham Alabama 35294
A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer
Arizona
Saint Joseph's Hospital and Medical Center
Phoenix Arizona 85013
A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer
District of Columbia
Georgetown University Hospital
Washington District of Columbia 20007
A clinical research study of Quadrivalent HPV for types 6, 11, 16 and 18 for the treatment of Cervical Cancer, Hpv or Warts
Childrens National Medical Center
Washington District of Columbia 20010
A clinical research study of Quadrivalent HPV for types 6, 11, 16 and 18 for the treatment of Cervical Cancer, Hpv or Warts
Florida
GSK Investigational Site
Miami Florida 33136Updated
Patients are needed to participate in a clinical research study of Gynaecological follow-up to evaluate Human Papillomavirus (HPV) Type 16/18 Infections or Cervical Neoplasia
Georgia
Memorial Health University Medical Center
Savannah Georgia 31403
A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer
Hawaii
GSK Investigational Site
Honolulu Hawaii 96826Updated
Patients are needed to participate in a clinical research study of Gynaecological follow-up to evaluate Human Papillomavirus (HPV) Type 16/18 Infections or Cervical Neoplasia
Iowa
GSK Investigational Site
Iowa City Iowa 52242Updated
Patients are needed to participate in a clinical research study of Gynaecological follow-up to evaluate Human Papillomavirus (HPV) Type 16/18 Infections or Cervical Neoplasia
GSK Investigational Site
Iowa City Iowa 52242
Patients are needed to participate in a clinical research study of Gynaecological follow-up, Cervarix™ and Placebo control to evaluate Human Papillomavirus Infection or Cervical Neoplasia
Kansas
GSK Investigational Site
Wichita Kansas 67207
Patients are needed to participate in a clinical research study of Gynaecological follow-up, Cervarix™ and Placebo control to evaluate Human Papillomavirus Infection or Cervical Neoplasia
Maryland
Johns Hopkins University
Baltimore Maryland 21287-8936
A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer
Missouri
Washington University School of Medicine
St. Louis Missouri 63110
A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer
New Mexico
GSK Investigational Site
Albuquerque New Mexico 87131Updated
Patients are needed to participate in a clinical research study of Gynaecological follow-up to evaluate Human Papillomavirus (HPV) Type 16/18 Infections or Cervical Neoplasia
New York
Montefiore Medical Center-Weiler Division
Bronx New York 10461
A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer
Memorial Sloan-Kettering Cancer Center
New York New York 10022
A clinical trial seeking patients for a research study of compound 31543 Calcitriol
North Carolina
Carolinas Medical Center
Charlotte North Carolina 28203
A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer
Ohio
Athens Ohio 45701
Patients are needed to participate in a clinical research study to evaluate Uterine Cervical Cancer
Case Western Reserve University
Cleveland Ohio 44106
A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer
Gallipolis Ohio 45631
Patients are needed to participate in a clinical research study to evaluate Uterine Cervical Cancer
Logan Ohio 43138
Patients are needed to participate in a clinical research study to evaluate Uterine Cervical Cancer
Lake University Ireland Cancer Center
Mentor Ohio 44060
A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer
View More »
Pomeroy Ohio 45769
Patients are needed to participate in a clinical research study to evaluate Uterine Cervical Cancer
Oklahoma
University of Oklahoma Health Sciences Center
Oklahoma City Oklahoma 73104
A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer
Texas
UT MD Anderson Cancer Center
Houston Texas 77030
Patients are needed to participate in a clinical research study evaluating Interview and Questionnaire
Washington
GSK Investigational Site
Wenatchee Washington 98801
Patients are needed to participate in a clinical research study of Gynaecological follow-up, Cervarix™ and Placebo control to evaluate Human Papillomavirus Infection or Cervical Neoplasia
Australia
GSK Investigational Site
Perth Western Australia Updated
Patients are needed to participate in a clinical research study of Gynaecological follow-up to evaluate Human Papillomavirus (HPV) Type 16/18 Infections or Cervical Neoplasia
Brazil
GSK Investigational Site
Campinas 13083-970
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
GSK Investigational Site
Campinas 13083-970Updated
Patients are needed to participate in a clinical research study of Gynaecological follow-up to evaluate Human Papillomavirus (HPV) Type 16/18 Infections or Cervical Neoplasia
GSK Investigational Site
Curitiba 80060-150Updated
Patients are needed to participate in a clinical research study of Gynaecological follow-up to evaluate Human Papillomavirus (HPV) Type 16/18 Infections or Cervical Neoplasia
GSK Investigational Site
Porto Alegre Rio Grande Do Sul 90035-003
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
GSK Investigational Site
Porto Alegre Rio Grande Do Sul 90035-003Updated
Patients are needed to participate in a clinical research study of Gynaecological follow-up to evaluate Human Papillomavirus (HPV) Type 16/18 Infections or Cervical Neoplasia
View More »
GSK Investigational Site
Ribeirão Preto São Paulo 14049-900
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
GSK Investigational Site
São Paulo 03015000
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
Canada
GSK Investigational Site
Edmonton Alberta T6G 2C8
Patients are needed to participate in a clinical research study of Gynaecological follow-up, Cervarix™ and Placebo control to evaluate Human Papillomavirus Infection or Cervical Neoplasia
GSK Investigational Site
Halifax Nova Scotia B3K 6R8
Patients are needed to participate in a clinical research study of Gynaecological follow-up, Cervarix™ and Placebo control to evaluate Human Papillomavirus Infection or Cervical Neoplasia
GSK Investigational Site
Sherbrooke Quebec J1H 1Z1
Patients are needed to participate in a clinical research study of Gynaecological follow-up, Cervarix™ and Placebo control to evaluate Human Papillomavirus Infection or Cervical Neoplasia
GSK Investigational Site
Truro Nova Scotia B2N 1L2
Patients are needed to participate in a clinical research study of Gynaecological follow-up, Cervarix™ and Placebo control to evaluate Human Papillomavirus Infection or Cervical Neoplasia
GSK Investigational Site
Vancouver British Columbia V6H 3N1
Patients are needed to participate in a clinical research study of Gynaecological follow-up, Cervarix™ and Placebo control to evaluate Human Papillomavirus Infection or Cervical Neoplasia
China
Cancer Institute & Hospital Chinese Academy of Medical Sciences
Beijing 100021
A clinical trial seeking patients for a research study of HPV Vaccine and HEV vaccine
Jiangsu Provincial Centre for Disease Control and Prevention
Nanjing Jiangsu 210009
Patients are needed to participate in a clinical research study evaluating Human papillomavirus type 16/18 Bivalent Vaccine and HBV vaccine for the treatment of Cervical Intraepithelial Neoplasia or Cervical Cancer
Croatia
University Hospital for Infectious Diseases, Croatia
Zagreb 10 000
A clinical trial seeking patients for a research study for the treatment of Cervical Cancer
Denmark
Hvidovre Hospital
Hvidovre
A clinical research study of BD HPV assay on Viper LT for the treatment of Uterine Cervical Neoplasms
Finland
GSK Investigational Site
Aanekoski 44100
A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection
GSK Investigational Site
Hameenlinna 13100
A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection
GSK Investigational Site
Helsinki 00100
A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection
GSK Investigational Site
Helsinki 00610Updated
Patients are needed to participate in a clinical research study of Gynaecological follow-up to evaluate Human Papillomavirus (HPV) Type 16/18 Infections or Cervical Neoplasia
GSK Investigational Site
Hyvinkaa 05800
A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection
View More »
GSK Investigational Site
Iisalmi 74100
A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection
GSK Investigational Site
Jamsa 42100
A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection
GSK Investigational Site
Jarvenpaa 04400
A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection
First 1 2 3 Last